Range
16.42 - 18.02
Vol / Avg.
34.3K/207.8K
Div / Yield
-
52 Wk
14 - 23.1
Mkt Cap
610.4M
Payout Ratio
-
Open
16.77
P/E
-
Shares
34.5M
Outstanding
34.5M
Total Float
22.6M
Cyteir Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing the next generation of precision oncology medicines that inhibit DNA damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. Its lead program, CYT-0851, as well as next-generation drug candidate CYT-1853, exploits a novel gain-of-function synthetically lethal relationship between overexpression of a family of DNA damaging genes called cytidine deaminases, and functional inhibition of homologous recombination, a DNA repair pathway critical for the survival of some cancers.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-23
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CYTCyteir Therapeutics6.43%610.4M

Cyteir Therapeutics Frequently Asked Questions

Q

How do I buy Cyteir Therapeutics (CYT) stock?

A

You can purchase shares of Cyteir Therapeutics (NASDAQ: CYT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cyteir Therapeutics's (CYT) competitors?

A

There are no as such competitors for Cyteir Therapeutics.

Q

What is the target price for Cyteir Therapeutics (CYT) stock?

A

The latest price target for Cyteir Therapeutics (NASDAQ: CYT) was reported by Wedbush on July 13, 2021. The analyst firm set a price target for 40.00 expecting CYT to rise to within 12 months (a possible 125.86% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cyteir Therapeutics (CYT)?

A

The stock price for Cyteir Therapeutics (NASDAQ: CYT) is $17.71 last updated Today at 6:46:57 PM.

Q

Does Cyteir Therapeutics (CYT) pay a dividend?

A

There are no upcoming dividends for Cyteir Therapeutics. The last dividend paid out to investors was $0.01 on November 6, 2015.

Q

When is Cyteir Therapeutics (NASDAQ:CYT) reporting earnings?

A
Cyteir Therapeutics’s Q2 earnings are confirmed for after-market on August 23, 2021.
Q

Is Cyteir Therapeutics (CYT) going to split?

A

There is no upcoming split for Cyteir Therapeutics.

Q

What sector and industry does Cyteir Therapeutics (CYT) operate in?

A

Cyteir Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.